Amarin Corp PLC (STU:EH3A)
€ 0.442 -0.038 (-7.92%) Market Cap: 197.44 Mil Enterprise Value: -83.88 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 38/100

Amarin Corporation PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 01:15PM GMT
Release Date Price: €3.04 (+7.42%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Hey, good morning, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. We're continuing the 40th Healthcare Conference today with Amarin. I'm joined by the company's CEO, Karim Mikhail. He's going to give a presentation, and then we're going to do some Q&A afterwards. (Operator Instructions) So with that, let me pass it over to Karim.

Karim Mikhail
Amarin Corporation plc - President, CEO & Director

Thank you, Jessica, and good morning, everyone. In today's presentation, I may make forward-looking statements for a complete of risk factors associated with investing in Amarin, please refer to our SEC filing.

So at Amarin, we have a bold vision to stop heart disease from being a leading cause of test. And in today's world, and I'm today on Slide #4, it is very bold as a vision because people don't realize it, but cardiovascular disease is really maybe the most enormous and worsening public health problem we have today.

And whether

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot